Key result
Geometrical confinement on low-stiffness substrates enhances iPSC-derived cardiac organoid maturity and electrophysiological function.
Why the study?
Advanced in vitro modeling requires recapitulating complex cardiac pathophysiology, driving interest in iPSC-derived 3D organoids that self-assemble and rebuild organ parts.
A novel iPSC-based cardiac organoid model utilizing geometrical confinement and low substrate stiffness successfully recapitulates relevant cardiac features and responds to chronotropic drugs, offering a potential platform for in vitro drug testing.
May advance iPSC cardiac organoid models for drug testing; leaves open human validation and clinical translation.
Induced pluripotent stem cells (iPSCs), carrying the patient's genetic background, open the path to advanced in vitro modeling. The feasibility of recapitulating complex pathophysiological scenarios depends on iPSC's ability to differentiate into the plurality of specific organ resident cells, on their maturation and networking. To this end, a strong interest has arisen in organoids, 3D structures, obtained by exploiting iPSC natural capability to self-assemble and rebuild organ parts. In this study, we describe the characterization of a novel iPSC-based cardiac organoid (CO) model, generated by a high-throughput and cost-effective method. Organoids were obtained by culture onto substrates of known stiffness, under geometrical confinement and inducing cardiac differentiation by small-molecule-based modulation of Wnt pathway. COs were characterized using a multi-omic approach (including bulk/single-cell RNA-sequencing, and proteomic analysis), immunofluorescence, electrophysiology (patch clamp), and optical recording-based contraction measurements. Results showed that COs recapitulate relevant cardiac features, including spontaneous contraction, multicellularity (e.g., cardiomyocytes, fibroblasts, epicardial layer) and chamber organization. Moreover, modulation of environmental mechanical cues showed a significant effect on organoid cardiac features. In particular, culturing organoids onto substrates of low stiffness, in the range of that characterizing the embryonal surrounding, enriched the gene sets related to cardiac maturity and cardiomyocyte ultrastructure. Functionally, different cardiac-specific ionic currents and consistent spontaneous action potentials were recorded upon patch-clamp of cardiomyocytes dissociated from COs. Finally, the beating rate of the whole COs was monitored non-destructively via video recording and quantified, demonstrating their response to clinically used chronotropic compounds, supporting the feasibility of future implementation of the proposed COs as in vitro platform for drug testing.
No takes yet. Share an insight, caveat, or question.
Santoro et al. (2025) studied In vitro cardiac organoid modeling. Geometrical confinement and low substrate stiffness (4 kPa) vs. Unconfined embryoid bodies and high stiffness substrates was evaluated on Organoid cardiac features and maturity (gene expression, electrophysiology, contraction). Culturing iPSC-derived cardiac organoids under geometrical confinement on low-stiffness substrates (4 kPa) significantly enhanced cardiac maturity, multicellularity, and functional electrophysiological features.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: